Finance

Lists
Why is GTBP down 2,64%?
Dive Deeper
GTBP:NASDAQ
GT Biopharma Inc
USD 4,42
-2,64%
(-0,12) 1D
6 Nov., 16:00:01 GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for GTBP...
Open
USD 4,53
High
USD 4,65
Low
USD 4,21
Mkt. cap
9,11 m
Avg. vol.
56,02 k
Volume
50,49 k
52-wk high
USD 28,75
52-wk low
USD 4,21
EPS
-USD 35,41
Beta
0,88
Shares outstanding
2,06 m
No. of employees
1
Open
USD 4,53
High
USD 4,65
Low
USD 4,21
Mkt. cap
9,11 m
Avg. vol.
56,02 k
Volume
50,49 k
52-wk high
USD 28,75
52-wk low
USD 4,21
EPS
-USD 35,41
Beta
0,88
Shares outstanding
2,06 m
No. of employees
1
News stories
From web sources and news partners
About GT Biopharma Inc
CEO-
Employees1
Founded1965
HeadquartersSan Francisco, Kalifornië, Verenigde State van Amerika
SectorHealth Care
Industry-
Websitegtbiopharma.com
Analyst ratings
Based on 1 analyst giving stock ratings to GTBP in the past 3 months
Buy
Buy
1
Hold
0
Sell
0
12-month forecast
Based on 1 Wall Street analyst offering 12-month price targets for GTBP in the last 3 months
Highest
Current USD 4,42
USD 3,00 (-32,13%)
Average
USD 3,00 (-32,13%)
Lowest
USD 3,00 (-32,13%)
Analyst
Recommendation
Action
Price target
Projected
Date
Jonathan Aschoff
Roth MKM
Buy
Maintained
USD 3,00
-32,1%
08/17/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
634,00 k
1,38 m
413,00 k
1,06 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2,75 m
4,22 m
2,44 m
3,46 m
Operating expense
3,38 m
5,60 m
2,85 m
4,51 m
Total operating expenses
3,38 m
5,60 m
2,85 m
4,51 m
Operating income
-3,38 m
-5,60 m
-2,85 m
-4,51 m
Other non operating income
232,00 k
-17,33 m
11,00 k
-
EBT including unusual items
-3,11 m
-23,03 m
-2,83 m
-4,52 m
EBT excluding unusual items
-3,11 m
-23,03 m
-2,83 m
-4,52 m
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-3,11 m
-23,03 m
-2,83 m
-4,52 m
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
36,00 k
17,00 k
67,00 k
58,00 k
Interest expense
-
-127,00 k
-63,00 k
-64,00 k
Net interest expenses
36,00 k
-110,00 k
4,00 k
-6,00 k
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google-programme